FAP and neoplasm: FAP-TAC constructs comprising linked ScFv antibodies specific for human FAP and CD3 were designed and used to generate EnAd viruses expressing the FAP-TAC transgene such that expression was under the virus major late promoter (MLP) to allow broad or tumor-selective expression, respectively.